| |
Our portfolio
Our
portfolio | Investment Guidelines |
Valuation Guidelines
|
Performance of ProgressNow!
|
as
per 30.04.2013
|
| Share price (SWX Swiss
Exchange) |
CHF 6.60 |
| Performance since 1.1.2013 |
-5.0% |
| Net Asset Value (preliminary unaudited
figure) |
CHF 8.02 |
|
Portfolio
|
as per 30.04.2013 |
| Company |
Amount |
Historical
price |
Current
valuation
per share |
+ / - |
Fair value
(in CHF) |
% of
portfolio |
| Enablearning, Inc | 1'452'905 | USD 0.87 | USD 0.00 | -100.0% | 0.00 | 0.0% | | Hansen Medical, Inc | 63'011 | USD 5.60 | USD 1.96 | -65.0% | 114'547.70 | 2.4% | | Oceanlinx Ltd | 348'179 | AUD 2.00 | AUD 0.35 | -82.5% | 116'269.15 | 2.4% | | Velico Medical, Inc | 9'906'585 | USD 0.92 | USD 0.50 | -45.6% | 4'594'178.79 | 95.2% |
|
Total (in CHF)
|
4'824'995.65 |
100.0% |
Exchange rate in CHF | | USD | 0.9275 | | AUD | 0.9541 | | GBP | 1.4426 |
|
|
